Company Filing History:

8 out of 521

Burroughs Wellcome Co.

patents

5. 2 out of 832,680

Other

patents

Years Active: 1978-2001

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6297276 - Substituted urea and isothiourea derivatives as no synthase inhibitors (2001-10-02),

2. 6225305 - Substituted urea and isothiorea derivatives as no synthase inhibitors (2001-05-01),

3. 6187789 - Substituted isoquinolines as ultra short acting neuromuscular blockers (2001-02-13),

4. 6177445 - Substituted isoquinolines as ultra short acting neuromuscular blockers (2001-01-23),

5. 5393883 - Antiviral combinations and compounds therefor (1995-02-28),

6. 5175165 - Antiviral combinations and compounds therefor (1992-12-29),

7. 5019577 - Novel compounds and use (1991-05-28),

8. 4971973 - Glutamic acid derivatives (1990-11-20),

9. 4921836 - Substituted glutamic acids (1990-05-01),

10. 4701455 - Biopterin analogs (1987-10-20),

11. 4665182 - Biopterin analogs (1987-05-12),

12. 4587340 - Biopterin analogs (1986-05-06),

13. 4488994 - Bis-esters of methanediol with penicillins and penicillanic acid (1984-12-18),

14. 4432903 - Bis-esters of methanediol with penicillins and penicillanic acid (1984-02-21),

15. 4377524 - Bis-esters of methanediol with penicillins and penicillanic acid (1983-03-22),

Title: Eric C Bigham: Innovator in Medicinal Chemistry

Introduction

Eric C Bigham is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicinal chemistry, holding a total of 18 patents. His work primarily focuses on the development of novel compounds that have therapeutic applications.

Latest Patents

Among his latest patents, Bigham has developed substituted urea and isothiourea derivatives as nitric oxide synthase inhibitors. These compounds are particularly useful in the treatment of conditions such as cerebral ischemia. The patents detail the use of N-substituted urea derivatives for the manufacture of medicaments aimed at inhibiting the NO synthase enzyme. Additionally, the patents describe novel N-substituted urea derivatives and the processes for their preparation.

Career Highlights

Bigham has had a distinguished career, working with notable companies such as Burroughs Wellcome Co. and Pfizer Corporation. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical development.

Collaborations

Throughout his career, Bigham has collaborated with esteemed colleagues, including Charles A Nichol and John F Reinhard, Jr. These partnerships have further enriched his research and innovation efforts.

Conclusion

Eric C Bigham's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of therapeutic solutions for critical health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.